1. Home
  2. US Senate Confirms Nikki Haley For US Ambassador To The UN With Huge Margin

US Senate Confirms Nikki Haley For US Ambassador To The UN With Huge Margin

[email protected] (Agencies)
January 25, 2017

Washington, Jan 25: The Senate confirmed President Donald Trump's pick for US ambassador to the United Nations by a decisive margin on Tuesday as Republican-led committees paved the way for three more of his Cabinet nominees to be approved just days into the new administration. South Carolina Governor Nikki Haley won strong support for the UN post despite her lack of foreign policy experience. Senators voted 96-4 on Ms Haley's nomination. Senator Bob Corker of Tennessee, the Republican chairman of the Foreign Relations Committee, said Ms Haley is a proven leader who will be a "fierce advocate" at the UN for American interests.

nikkihaley

But not everyone was sold. Senator Chris Coons, D-Del., said Ms Haley didn't convince him that she'll serve effectively. The US ambassador to the international body should be an expert on international affairs, Mr Coons said, "not someone who will be learning on the job."

A Senate vote is expected soon on Mr Trump's choice for secretary of state, former Exxon Mobil CEO Rex Tillerson. The Foreign Relations Committee narrowly approved his nomination Monday, 11-10. No Democrats on the panel voted for Mr Tillerson.

Mr Tillerson's bid got a key boost when Senator Joe Manchin, D-W.Va, announced his support Tuesday. Mr Manchin, who faces re-election in 2018 in a state that backed Mr Trump heavily in the presidential election, said Mr Tillerson's extensive business career "will bring a unique perspective to the State Department."

The vote on Ms Haley capped a day when the GOP-led panels endorsed Mr Trump's choices to lead the Transportation, Housing, and Commerce departments. Yet congressional Republicans criticized Democrats for not moving quickly enough on all of the president's selections.

Senator Dianne Feinstein of California, the top Democrat on the Senate Judiciary Committee, forced a one-week delay - until January 31 - of the committee's vote on Mr Trump's attorney general nominee, Senator Jeff Sessions.

Ms Feinstein said senators "owe it" to the more than 1 million women who marched in Washington and other locations on Saturday to be careful in considering Sessions' nomination and his willingness to protect equal rights. She also said the committee received 188 pages of new material that needs to be reviewed. Committee rules allow any member of the panel to delay a vote.

Deliberations over two of Mr Trump's picks turned testy as both nominees faced questions from Democrats over their personal finances. Rep. Tom Price, R-Ga., the president's choice for health secretary, defended his decision to invest in health care companies as he testified before the Senate Finance Committee.

Panel staffers found Mr Price undervalued around 400,000 shares of stock in Australian drug company Innate Immunotherapeutics that he purchased last August. He reported the shares were valued at $50,000 to $100,000, but those shares were worth up to $250,000. Mr Price blamed a "clerical error" and answered "no" when Sen. Ron Wyden, D-Ore., asked if he'd used poor judgment.

Senator Bernie Sanders, I-Vt., said Mr Trump's nominee for budget director, South Carolina Rep. Mick Mulvaney, should be disqualified because he failed to pay more than $15,000 in payroll taxes for a babysitter more than a decade ago. Mr Mulvaney said he discovered the unpaid taxes while preparing for the nominating process. He has since paid the taxes.

Mr Trump's choice for education secretary, Betsy DeVos, is also being scrutinised by Democrats about her qualifications, political donations and longtime work advocating for charter schools and school choice in her home state of Michigan.

Sen. Gary Peters, D-Mich., delivered a withering critique of DeVos on Tuesday, saying he has no confidence she will fully support traditional public schools and students.

The Senate Commerce Committee approved by voice votes Mr Trump's choices of conservative billionaire investor Wilbur Ross to run the Commerce Department and Elaine Chao to lead the Transportation Department.

Mr Ross has specialized in buying distressed companies that still have a potential for delivering profits. He has known Mr Trump for more than 20 years, was an early supporter of his presidential campaign and served as an economic policy adviser to Mr Trump's team.

Ms Chao, an experienced Washington hand, was labor secretary in President George W Bush's administration and deputy transportation secretary under President George HW Bush. She is also the wife of Senate Majority Leader Mitch McConnell of Kentucky.

Ms Chao is expected to play a major role in Mr Trump's effort to fulfill his campaign promise to generate $1 trillion in infrastructure investment.

Ben Carson, nominated to lead the Department of Housing and Urban Development, won unanimous approval from the Senate Banking, Housing and Urban Affairs Committee. The former Republican presidential candidate and celebrated neurosurgeon would lead a sprawling agency with 8,300 employees and a budget of about $47 billion.

Senator Michael Crapo of Idaho, the committee's Republican chairman, praised Carson and said the department "will benefit from having a secretary with a different perspective and a diverse background." Sen. Sherrod Brown of Ohio, the panel's top Democrat, said he had reservations but welcomed Carson's promises to address lead hazards in public housing.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 16,2020

Brussels/Amsterdam, Apr 16: As the novel coronavirus continues to wreak havoc in the western world since its outbreak in Wuhan last December, researchers believe that the Chinese leadership is trying to absolve President Xi Jinping by using a section of the western media to influence public opinion globally.

"There are clear indications that China is conducting activities in a persistent and systematic manner to influence public opinion-making, academia, think tanks and political decision-making among the member states of the Belt and Road Initiative (BRI) in general and western capital cities in particular," Siegfried O Wolf, Director of Research at Brussels-based think tank South Asia Democratic Front, said.

Some western media say some Chinese officials were secretly aware that they were facing a pandemic from the new coronavirus but allowed Wuhan to host a mass banquet for tens of thousands of people and millions began their annual trip home for the Lunar New Year celebrations.

The pandemic has since then affected 210 countries and territories around the world. Over 2 million people have been declared positive in which over 134,000 lost their lives.

"The frequency and extra-ordinary large scale of Chinese sponsored events in European political hubs, like in Brussels, and the subsequent media coverage can be seen as evidence for Beijing's public diplomacy efforts. However, the rising skepticism within the EU regarding Xi Jinping's development projects and the emerging questioning of Chinese sources funding Free Universities, like the one in Berlin, shows that this strategy produced mixed results so far," Wolf said.

He added, "However, one must also state that these efforts helped China to gain certain leverage among many non-Chinese media, western as well as non-western ones. Today, we can observe that China's political leadership tries to instrumentalise this influence for a major image campaign to distract from the fact that it carries the initial responsibility for the dramatic spread of COVID-19 by holding back key information."

Wolf also said that the current internal dynamics in China, like the shirking of responsibilities by the local authorities, are most-likely part of a twofold strategy. Firstly, there is the strategic component - namely, to reaffirm to the general public that the Communist Party of China is still in full control of the situation. The second strategic pillar is one of 'whitewashing'.

"Concretely, Beijing's obvious aim is to distract the domestic and international attention from the real, but hidden causes of the Coronavirus outbreak and its potential reputational and political consequences for Xi Jinping and his BRI," he stated.

Yoana Barakova, a Research Analyst at European Foundation for South Asian Studies (EFSAS), an Amsterdam-based think-tank, said, "The death of Dr. Li Wenliang, one of the very few medical professionals who tried to warn the world in December 2019 about the looming threat, sparked widespread condemnation around the international community in early February. Yet, little did he know that his legacy would continue much later after his demise, with the emboldened Chinese government trying to cover up its missteps through hardcore censorship after being exposed for undermining and underestimating the initial danger."

The researchers believe that the deterioration in press freedom under Jinping's regime has become more evident in recent days, with local authorities trying to control the state narrative by cosmetically placing media's focus on government's superficial attempts to tackle the crisis.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 13,2020

Shanghai, Jun 13: Authorities in Beijing have temporarily shut a major wholesale agricultural market following a rise in locally transmitted novel coronavirus infections in China's capital city over the past two days.

The closure of the Xinfadi wholesale market at 3 a.m. local time on Saturday (1900 GMT on Friday), came after two men working at a meat research centre who had recently visited the market were reported on Friday as having been infected by the novel coronavirus. It was not immediately clear how the men had been infected.

Concern is growing of a second wave of the new virus, even in many countries that seemed to have curbed its spread. It was first reported at a seafood market in Wuhan, the capital of central China's Hubei province, in December.

Beijing authorities had earlier halted beef and mutton trading at the Xinfadi market, alongside closures at other wholesale markets around the city.

Reflecting concerns over the risk of further spread of the virus, major supermarkets in Beijing removed salmon from their shelves overnight after the virus causing COVID-19 was discovered on chopping boards used for imported salmon at the market, the state-owned Beijing Youth Daily reported.

Beijing authorities said more than 10,000 people at the market will take nucleic acid tests to detect coronavirus infections. The city government also said it had dropped plans to reopen schools on Monday for students in grades one through three because of the new cases.

Health authorities visited the home of a Reuters reporter in Beijing's Dongcheng district on Saturday to ask whether she had visited the Xinfadi market, which is 15 km (9 miles) away. They said the visit was part of patrols Dongcheng was conducting.

Listen to the latest songs, only on JioSaavn.com

China reported 11 new COVID-19 cases and seven asymptomatic cases for Friday, the national health authority said on Saturday. And all six locally transmitted cases were confirmed in Beijing.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 7,2020

Russia boasts that it's about to become the first country to approve a Covid-19 vaccine, with mass vaccinations planned as early as October using shots that are yet to complete clinical trials -- and scientists worldwide are sounding the alarm that the headlong rush could backfire.

Moscow sees a Sputnik-like propaganda victory, recalling the Soviet Union's launch of the world's first satellite in 1957.

But the experimental Covid-19 shots began first-in-human testing on a few dozen people less than two months ago, and there's no published scientific evidence yet backing Russia's late entry to the global vaccine race, much less explaining why it should be considered a front-runner.

“I'm worried that Russia is cutting corners so that the vaccine that will come out may be not just ineffective, but also unsafe,” said Lawrence Gostin, a global public health law expert at Georgetown University. “It doesn't work that way... Trials come first. That's really important.”

According to Kirill Dmitriev, head of Russia's Direct Investment Fund that bankrolled the effort, a vaccine developed by the Gamaleya research institute in Moscow may be approved in days, before scientists complete what's called a Phase 3 study.

That final-stage study, usually involving tens of thousands of people, is the only way to prove if an experimental vaccine is safe and really works.

Health Minister Mikhail Murashko said members of “risk groups,” such as medical workers, may be offered the vaccine this month.

He didn't clarify whether they would be part of the Phase 3 study that is said to be completed after the vaccine receives “conditional approval.”

Deputy Prime Minister Tatyana Golikova promised to start “industrial production” in September, and Murashko said mass vaccination may begin as early as October.

Dr Anthony Fauci, the top US infectious disease specialist, questioned the fast-track approach last week.

“I do hope that the Chinese and the Russians are actually testing a vaccine before they are administering the vaccine to anyone, because claims of having a vaccine ready to distribute before you do testing I think is problematic at best," he said.

Questions about this vaccine candidate come after the US, Britain and Canada last month accused Russia of using hackers to steal vaccine research from Western labs.

Delivering a vaccine first is a matter of national prestige for the Kremlin as it tries to assert the image of Russia as a global power capable of competing with the US and China.

The notion of being “the first in the world” dominated state news coverage of the effort, with government officials praising reports of the first-step testing.

In April, President Vladimir Putin ordered state officials to shorten the time of clinical trials for a variety of drugs, including potential coronavirus vaccines.

According to Russia's Association of Clinical Trials Organizations, the order set “an unattainable bar” for scientists who, as a result, "joined in on the mad race, hoping to please those at power.”

The association first raised concern in late May, when professor Alexander Gintsburg, head of the Gamaleya institute, said he and other researchers tried the vaccine on themselves.

The move was a “crude violation of the very foundations of clinical research, Russian law and universally accepted international regulations" the group said in an open letter to the government, urging scientists and health officials to adhere to clinical research standards.

But a month later, the Health Ministry authorized clinical trials of the Gamaleya product, with what appeared to be another ethical issue.

Human studies started June 17 among 76 volunteers. Half were injected with a vaccine in liquid form and the other half with a vaccine that came as soluble powder.

Some in the first half were recruited from the military, which raised concerns that servicemen may have been pressured to participate.

Some experts said their desire to perform well would affect the findings. “It's no coincidence media reports we see about the trials among the military said no one had any side effects, while the (other group) reported some," said Vasily Vlassov, a public health expert with Moscow's Higher School of Economics.

As the trials were declared completed and looming regulatory approval was announced last week, questions arose about the vaccine's safety and effectiveness.

Government assurances the drug produced the desired immune response and caused no significant side effects were hardly convincing without published scientific data describing the findings.

The World Health Organization said all vaccine candidates should go through full stages of testing before being rolled out.

“There are established practices and there are guidelines out,” WHO spokesman Christian Lindmeier said Tuesday.

“Between finding or having a clue of maybe having a vaccine that works, and having gone through all the stages, is a big difference.”

Offering an unsafe compound to medical workers on the front lines of the outbreak could make things worse, Georgetown's Gostin said, adding: “What if the vaccine started killing them or making them very ill?”

Vaccines that are not properly tested can cause harm in many ways — from a negative impact on health to creating a false sense of security or undermining trust in vaccinations, said Thomas Bollyky, director of the global health program at the Council on Foreign Relations. 

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.